Showing Funds Performance since Sep 07, 2020

| Duration | Fund Return(%) | Category Average(%) | Category Best(%) |
|---|---|---|---|
| 1M | 5.82 | -0.98 | 13.35 |
| 6M | 10.07 | 0.58 | 111.48 |
| 1Y | 19.12 | 2.95 | 221.92 |
| 3Y | 0.00 | 8.79 | 353.35 |
HDFC Pharma and Healthcare Fund Growth managed by HDFC Mutual Fund,is a Equity - Sector Fundscheme with Assets Under Management of ₹2,159 Crore. The fund benchmarks its performance against the BSE Healthcare while maintaining an expense ratio of 2.88. Under the expert guidance of Nikhil Mathur ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.
Mr. Nikhil Mathur holds PGDM - IMT, Ghaziabad, B.E. (Civil) - PEC, Chandigarh, CFA (USA) level 3 cleared. He has over 7 years of experience in equity research and 2 years in financial advisory.
| Fund Name | Ratings | AUM | Expense Ratio |
|---|---|---|---|
| LIC MF Technology Fund Growth | 0 | 82.18 CR | 2.21 |
| Kotak MNC Fund Growth | 0 | 2047.91 CR | 2.06 |
| HDFC Pharma and Healthcare Fund Growth | 0 | 2158.58 CR | 2.88 |
| ICICI Prudential PSU Equity Fund Growth | 2 | 1975.03 CR | 2.38 |
| Nippon India Taiwan Equity Fund Growth | 3 | 1138.67 CR | 2.17 |
| Fund Name | 1Y | 3Y |
|---|---|---|
| This FundLIC MF Technology Fund Growth | 0 | 0 |
| This FundKotak MNC Fund Growth | 21.9475 | 0 |
| This FundHDFC Pharma and Healthcare Fund Growth | 19.1225 | 0 |
| This FundICICI Prudential PSU Equity Fund Growth | 5.8624 | 95.6132 |
| This FundNippon India Taiwan Equity Fund Growth | 217.5205 | 334.9188 |